UBS lowered the firm’s price target on Five9 to $81 from $90 and keeps a Buy rating on the shares. The Q1 revenue beat and reiteration of the FY24 revenue growth guidance likely met expectations, and but the debate still centers on the on the achievability of the implied 2H revenue growth acceleration to 20% year over year, and the Q2 revenue growth guidance of 10% year over year may add to skepticism, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FIVN:
